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OBJECTIVES The goal of this study was to describe the core laboratory angiographic findings of “SHould
we emergently revascularize Occluded Coronaries for cardiogenic shocK” (SHOCK) trial
participants and to determine the relationship of angiographic parameters to one-year
survival.
BACKGROUND In the SHOCK trial, emergency revascularization improved one-year survival of patients with
cardiogenic shock compared with initial medical stabilization including thrombolysis and
intraaortic balloon counterpulsation.
METHODS Coronary angiography was performed by protocol in 147 of 152 (97%) patients in the
emergency revascularization (ERV) group and by clinical selection in 100 of 150 (67%)
patients in the initial medical stabilization (IMS) group. Of the other 50 IMS patients, 45 of
50 (90%) died rapidly and did not undergo angiography.
RESULTS Left ventricular ejection fraction was correlated with one-year survival in both treatment
groups (p  0.001). In the IMS group, the hazard ratio for death was 2.59 (95% confidence
interval 1.47 to 4.58, p  0.001) per diseased vessel (0/1 vs. 2 vs. 3). In the ERV group, the
hazard ratio for death per diseased vessel was 1.11 (95% confidence interval 0.79 to 1.56, p 
0.559). Multivariate analysis of the angiography cohort (without regard for left ventriculo-
gram measurements) identified initial Thrombolysis in Myocardial Infarction flow grade (p
0.032), number of diseased vessels (for IMS patients only, p 0.024), and culprit vessel (p
0.004) as independent correlates of one-year survival, even after adjustment for key clinical
factors. In the smaller cohort with left ventricular ejection fraction measured (n  97),
ejection fraction and culprit vessel remained independently correlated with survival.
CONCLUSIONS For patients in cardiogenic shock, left ventricular function and culprit vessel were indepen-
dent correlates of one-year survival. (J Am Coll Cardiol 2003;42:1373–9) © 2003 by the
American College of Cardiology Foundation
Important predictors of survival in patients with coronary
artery disease include age, severity of angina or ischemia,
See page 1387
extent of coronary artery disease, patency of the infarct-
related artery, and left ventricular function (1–11). In
patients with cardiogenic shock complicating acute myocar-
dial infarction, the multicenter randomized trial entitled
“SHould we emergently revascularize Occluded Coronaries
for cardiogenic shocK” (SHOCK) trial has demonstrated
that emergency revascularization by percutaneous coronary
intervention (PCI) or coronary artery bypass surgery
(CABG) improves one-year survival in patients with car-
diogenic shock due to left ventricular failure as compared
with patients treated with initial medical stabilization
(12,13), with 13 lives saved per 100 patients treated. Core
laboratory angiographic findings from the SHOCK trial
were examined in order to describe the angiographic profile
of patients in cardiogenic shock and to determine the
correlates of one-year survival using multivariate analysis.
METHODS
Trial design. The study design was a randomized trial at
36 international centers comparing the two treatment strat-
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egies of emergency revascularization (ERV) and initial
medical stabilization (IMS). Each center obtained institu-
tional review committee approval (12,14). By protocol,
enrolled patients had shock onset within 36 h of myocardial
infarction and were randomized within 12 h of shock onset.
Patients assigned to the ERV group had to have angioplasty
or bypass surgery as soon as possible and within 6 h of
randomization; intraaortic balloon counterpulsation was
recommended for both groups. For patients assigned to the
IMS group, thrombolytic therapy was strongly recom-
mended. In the latter group, delayed revascularization a
minimum of 54 h after randomization was encouraged if
clinically indicated, although coronary angiography was
allowed at any time. Complete details of study design and
eligibility criteria are previously described (14). The angio-
graphic analysis reported in this study is based on studies
performed before revascularization.
Angiographic core laboratory protocol. All coronary and
left ventricular cineangiograms were reviewed at the core
laboratory (New York Hospital) using the Thrombolysis In
Myocardial Infarction (TIMI) criteria (15), the Rentrop
coronary collateral circulation classification (16), and an
estimate of the amount of myocardium at risk based on the
coronary artery jeopardy score (17). The angiographic pa-
rameters that were examined included: location, severity,
and morphology of all coronary lesions; TIMI flow; iden-
tification of ischemia related artery (culprit vessel) by elec-
trocardiogram and lesion morphology; modified American
Heart Association/American College of Cardiology culprit
lesion type (18,19); quantification of left ventricular func-
tion (20); amount of mitral regurgitation (MR) (0 to 4
scale); and presence of ventricular septal defect, flail mitral
leaflet, and left ventricular thrombus. Significant coronary
artery disease was defined as 50% diameter stenosis.
Patients with significant left main stenosis and left domi-
nant coronary anatomy were classified as having both left
main and three-vessel coronary artery disease. Each angio-
gram was read by two independent readers using standard-
ized data forms, with discrepancies resolved by a third
reader. All readers were blinded to treatment group and
enrolling center.
Statistical analysis. Categorical angiographic findings of
patients classified by treatment assignment were compared
using a Fisher exact test. Treatment group differences in
continuous variables were compared by Student’s t test for
age, systolic blood pressure, and heart rate and using the
Wilcoxon rank sum test for all other variables. For all
analyses of one-year survival, six patients who were trial
ineligible (five assigned to emergency revascularization and
one assigned to initial medical stabilization) due to severe
MR, aortic dissection, or left ventricular free wall rupture
identified after randomization were excluded. The Kaplan-
Meier method (21) was used to estimate survival curves by
coronary anatomy. Multivariate modeling of one-year sur-
vival was conducted using Cox proportional hazards regres-
sion. One patient with unknown one-year vital status was
excluded from survival curves and Cox modeling due to
informative censoring (patient not found in the Social
Security Death Index but not documented to be alive at one
year). Descriptive statistics are presented as means  SD,
medians and interquartile range, or as percentages. All
analyses were conducted with the Statistical Analysis Sys-
tem (SAS Institute, Inc., Cary, North Carolina) and S-Plus
software (Statistical Sciences, Inc., Seattle, Washington).
RESULTS
Baseline angiographic findings. A total of 302 patients
were randomized to emergency revascularization (n  152)
or initial medical stabilization (n  150). Coronary angiog-
raphy was performed, by protocol, on 147 of 152 (97%)
patients in the ERV group and 100 of 150 (67%) patients
selected from the IMS group. Five patients randomized to
emergency revascularization died before coronary angiogra-
phy could be performed. Of the 50 IMS patients who did
not undergo angiography, 45 (90%) died rapidly despite
having a similar mean age (67 11 vs. 66 11 years) as the
IMS patients who underwent angiography. The cardiac
index, however, was somewhat lower in these IMS patients
compared with those who underwent angiography (1.6 
0.5 vs. 1.8  0.5, p  0.093) and they were more likely to
have a history of peripheral vascular disease (25.8% vs. 8.3%,
p  0.027), and a history of bypass graft surgery (16.0% vs.
7.0%, p  0.092). Of a total of 247 coronary angiograms
performed, 243 could be interpreted, as three films were not
obtained, and one was of poor quality. In this angiographic
cohort of 243 patients, 90% of patients assigned to a strategy
of emergency revascularization and 37% of patients assigned
to initial medical stabilization with possible delayed revas-
cularization underwent revascularization (62% PCI, 38%
CABG for IMS and ERV). This cohort was 66  10 years
old and 33% female, with mean systolic blood pressure and
cardiac index on support measures of 89  21 mm Hg and
1.8  0.6 l/min/m2, respectively.
Coronary angiography revealed extensive, severe coronary
Abbreviations and Acronyms
CABG  coronary artery bypass grafting
ERV  emergency revascularization
IMS  initial medical stabilization
LAD  left anterior descending artery
LCX  left circumflex artery
LM  left main coronary artery
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MR  mitral regurgitation
PCI  percutaneous coronary intervention
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artery disease in both groups with almost two-thirds of the
patients having three-vessel disease and 21% having left
main disease (Table 1). By protocol design, angiography was
performed later after shock onset for IMS compared with
ERV patients (median 12.8 vs. 5.0 h), and the rate of
thrombolytic therapy use was higher in IMS patients (63.3%
vs. 49.3%). There were no significant differences in the
distribution of the number of diseased vessels or the rate of
left main coronary artery (LM) disease between groups. The
extent of coronary artery disease as measured by the coro-
nary artery jeopardy score was also similar in the IMS and
ERV groups (7.4  3.6 vs. 7.7  3.5, p  0.462). Almost
one-third (32%) had TIMI flow 3 in the culprit lesion at the
time of angiography. The distribution of initial flow differed
by treatment assignment with IMS patients more likely to
have a patent vessel (p  0.045) (Table 2). This finding was
expected due to the association between thrombolytic ther-
apy and TIMI flow (56% TIMI 2/3 flow in patients who
received thrombolytic therapy vs. 40% TIMI 2/3 flow in
those who did not). In addition, IMS patients were studied
later and, therefore, had a longer period of time for
thrombolysis to establish reperfusion.
Analysis of the left ventriculograms performed revealed
that the left ventricular ejection fraction (LVEF) (31 
12%, n  97) and the degree of MR (1.2  1.4, n  101)
were similar in the two groups. No ventricular septal defects
were noted in either group. There was a 2.3% incidence of
flail mitral leaflet and a 1.8% incidence left ventricular
thrombus noted in the IMS group.
Culprit lesion characteristics. The distribution of culprit
vessel location was similar for the two treatment groups (p
 0.298). The left anterior descending artery (LAD) was
the culprit vessel in 49% of patients, and the right coronary
artery (RCA) was the culprit vessel in 29% of patients
(Table 2). The left circumflex (LCX), LM, and saphenous
vein grafts (SVG) were less often culprit vessels. There was
no significant difference in the distribution of culprit lesion
types between the IMS and the ERV patients (p  0.188).
Relationship of angiographic findings to survival. Over-
all one-year survival for all patients in the ERV group was
47% and 34% for IMS (p  0.025) (13). The association
between the number of diseased coronary arteries and
one-year survival depended on treatment group (interaction
p  0.018). Disease severity was significantly correlated (p
 0.002) with one-year survival for the IMS group. How-
ever, in the ERV group the number of diseased coronary
arteries was not associated with survival. In the IMS group,
the hazard ratio for death was 2.59 (95% confidence interval
1.47 to 4.58, p  0.001) per diseased vessel (0/1 vs. 2 vs. 3).
In the ERV group, the hazard ratio for death per diseased
vessel was 1.11 (95% confidence interval 0.79 to 1.56, p 
0.559). Similarly, while coronary artery jeopardy score was
inversely correlated with one-year survival in the IMS group
(p  .001), this correlation was not observed (p  0.404) in
Table 1. SHOCK Trial Core Laboratory Angiographic Findings by Treatment Group Assignment
Characteristics n
Initial Medical
Stabilization n
Emergency
Revascularization p Value
Number randomized 150 152 –
Coronary angiography performed, n (%) 100 (67%) 147 (97%)  0.001
Number of angiograms reviewed 99 144
Median hours from shock onset to angiography* 100 12.8 [2.0, 108.4] 147 5.0 [2.6, 8.8]  0.001
Number of diseased vessels (%) 96 143 0.918
0 3.1 1.4
1 8.3 12.6
2 24.0 21.7
3 64.6 64.3
Left main coronary artery disease (%) 97 17.5 141 23.4 0.332
Jeopardy score 96 7.4  3.6 143 7.7  3.5 0.462
Left ventriculogram performed, n (%) 99 55 (55.6) 144 52 (36.4) 0.004
Left ventricular ejection fraction (%) 49 32.5  13.9 46 29.1  10.6 0.184
Mitral regurgitation (%) 54 1.2  1.3 47 1.2  1.6 0.756
0 44.4 55.3 0.871
1 18.5 6.4
2 20.4 17.0
3 9.3 4.3
4† 7.4 17.0
Ventricular septal defect (%) 54 0 50 0
Flail mitral leaflet (%) 43 2.3 43 0 1.00
Left ventricular thrombus (%) 55 1.8 48 0 1.00
*Eleven initial medical stabilization (IMS) and four emergency revascularization (ERV) patients underwent coronary angiography before shock onset. Values in brackets represent
25th to 75th percentiles. Times are presented for all 247 patients in the trial who underwent coronary angiography, although only 243 were reviewed. There was a bimodal
distribution of IMS angiography: half underwent angiography within 2 h of randomization and half 21 or more h postrandomization. Two patients had significant left main
stenosis with left dominant coronary anatomy without additional coronary artery disease and were, therefore, classified as having both left main and three vessel coronary artery
disease. †Four IMS and eight ERV patients had 4 mitral regurgitation (mean left ventricular ejection fraction 29.7%) observed on left ventriculogram. Two of these patients
were declared ineligible post-randomization and are excluded from survival analyses.
SHOCK  “SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK” trial.
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patients who were assigned to ERV (treatment group by
jeopardy score interaction, p  0.036). Of the IMS patients
who underwent angiography, those who underwent early
angiography (less than 2 h after randomization) had more
extensive coronary artery disease (72% three-vessel disease)
compared with those who underwent angiography several
days later, on average (more than 2 h after randomization)
(56% three-vessel disease). Thus, disease severity could
explain the high (90%) mortality in IMS patients who did
not undergo angiography.
Left ventricular ejection fraction was strongly correlated
with one-year survival in all patients (Fig. 1), with an odds
ratio for death of 0.68 per 5-unit increase in ejection
fraction (95% confidence interval 0.54 to 0.86, p  0.001).
Thus, for every 5-unit increase in baseline ejection fraction,
the odds of dying in one year were reduced by one-third.
This effect was independent of treatment group assignment
(interaction p  0.778). An increase in the amount of MR
was inversely associated with one-year survival in the IMS
group (p 0.017). This was not observed in the ERV group
(p  0.604) although the number of patients in some of
these categories was small (Table 3), and the treatment
group by MR grade interaction was not significant.
In ERV patients and those selected to undergo angiog-
raphy in the IMS group, the greatest one-year survival was
seen when the RCA was the culprit vessel (Table 3). Mean
LVEF was highest (39.1  14.1%) in patients with the
RCA as the culprit vessel. After adjustment for LVEF (n 
85), the survival of patients with a right coronary culprit
artery was similar to that of patients with a LAD culprit
artery but still higher than patients with either an LM,
LCX, or SVG culprit. In the IMS group, there was 100%
mortality at one year when the culprit vessel was the LM or
a SVG (six patients). Severity of culprit lesion type and
culprit lesion thrombus score did not have a significant
association with survival in either group. The majority of
patients (78%) had grade 0-1 collaterals to the culprit vessel.
Collateral score did not correlate with one-year survival in
either treatment group. In this study, a composite measure
of initial TIMI 2/3 flow or Rentrop 2/3 collateral score was
not associated with improved one-year survival compared
with low-flow states (TIMI 0/1 flow and Rentrop 0/1
collateral score).
Multivariate analysis. Cox proportional hazards regression
models for one-year survival were constructed, which con-
sidered all of the angiographic variables analyzed as well as
Table 2. Culprit Lesion Characteristics of SHOCK Trial Patients
Characteristics n
Initial Medical
Stabilization (%) n
Emergency
Revascularization (%) p Value
Culprit vessel 90 137 0.298
LAD 48 53.3 64 46.7
RCA 26 28.9 40 29.2
LCX 10 11.1 19 13.9
SVG 4 4.4 3 2.2
LM 2 2.2 11 8.0
Culprit lesion type 85 130 0.188
A 0 0.0 0 0.0
B1 34 40.0 42 32.3
B2 38 44.7 61 46.9
C 13 15.3 27 20.8
Culprit lesion TIMI flow 88 134 0.045
0 28 31.8 65 48.5
1 9 10.2 9 6.7
2 20 22.7 21 15.7
3 31 35.2 39 29.1
The vascular distribution supplied by the seven SVG culprit vessels were as follows: LAD (three), LCX (two), RCA (two).
LAD  left anterior descending artery; LCX  left circumflex artery; LM  left main; RCA  right coronary artery;
SHOCK  “SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK” trial; SVG  saphenous vein
graft; TIMI  Thrombolysis In Myocardial Infarction.
Figure 1. One-year survival estimates of “SHould we emergently revascu-
larize Occluded Coronaries for cardiogenic shocK” (SHOCK) trial patients
by left ventricular (LV) ejection fraction. Survival rates increase with
increasing ejection fraction (p  0.001), and this relationship is indepen-
dent of treatment assignment (interaction p  0.778). For each level of
ejection fraction, survival is better for emergency revascularization (ERV)
patients. Data frequency for ERV and initial medical stabilization (IMS)
patients is shown by fringe on top and bottom of the plot, respectively.
Three patients identified as ineligible after randomization due to severe
mitral regurgitation or LV free rupture were excluded.
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the following six clinical variables often found to be risk
factors in acute myocardial infarction or shock populations:
age, gender, systolic blood pressure, anterior myocardial
infarction, cardiac index, and pulmonary capillary wedge
pressure. Two final models were composed: one using left
ventriculogram data (44% of SHOCK angiography pa-
tients) and one without incorporating left ventriculogram
data. Table 4 summarizes the model that does not incorpo-
rate left ventriculogram measures (n  214). This model
includes increasing age, increasing number of diseased
vessels (in the IMS group, only a twofold increase in risk of
death with each additional diseased artery was found;
interaction p  0.084), decreasing initial TIMI flow grade,
and non-RCA culprit lesions as independent risk factors for
death at one year. Table 5 summarizes the left ventriculo-
gram model (n 73), which includes increasing age, female
gender, decreasing cardiac index and LVEF, decreasing
initial TIMI flow grade (in the ERV group only), and
non-RCA/non-LAD culprit lesions as independent risk
factors. The number of diseased coronary arteries is not an
independent predictor of survival in the IMS group in this
multivariate model because coronary anatomy correlated
with LVEF. Among patients with left ventriculograms,
mean LVEF was 46% for patients with 0 or 1 diseased
arteries, 33% for two-vessel disease, and 29% for three-
vessel disease.
DISCUSSION
Angiographic findings in the SHOCK trial revealed high
rates of LM and three-vessel coronary artery disease with a
predominance of LAD culprit arteries, initial TIMI 0, 1
flow, and complex lesion types. These findings suggest an
important role for further innovations in pharmacologic
(22) and catheter-based interventional approaches as well as
for urgent coronary artery bypass surgery, despite high risk.
Coronary artery bypass grafting was urgently performed in
39% of the SHOCK trial patients assigned to early revas-
cularization and was an important factor in the overall
improved one-year survival for this treatment group (12,13).
Nevertheless, in the National Registry of Myocardial In-
farction, the low rate of 2% to 5% early CABG for shock
patients has not changed between 1994 and 2001 (23). This
is in contrast to significantly increasing rates of PCI for
shock. The rapid death of 90% of IMS patients who did not
undergo angiography is a further indication for urgent
angiography and early revascularization.
In the presence of cardiogenic shock, LVEF, initial TIMI
flow, and culprit vessel were found to be independent
correlates of one-year survival. Interestingly, left ventricular
function measured with intraaortic balloon pump and ino-
tropic support was moderately, but not severely, depressed.
Similar levels of left ventricular dysfunction (LVEF, 29%)
are seen in patients with chronic congestive heart failure due
to ischemic heart disease with New York Heart Association
functional class II and III (24) and in early post-myocardial
infarction patients, with mild or no congestive heart failure
(LVEF, 33%) (25). This suggests a complex interplay of
acute changes in left ventricular performance and systemic
vascular resistance in the genesis of shock (26,27).
Normal TIMI 3 flow before mechanical reperfusion has
been found to be an independent determinant of survival in
an analysis from the Primary Angioplasty in Myocardial
Infarction (PAMI) trials; however, patients with cardio-
genic shock were excluded from those studies (28). Thus,
Table 3. Relationship of SHOCK Trial Core Laboratory
Angiographic Findings to One-Year Survival
Characteristics
One-Year Survival Rate
n % p Value*
Number of diseased vessels† 0.013/0.005
0/1 31 64.5
2 50 60.0
3 151 41.7
Mitral regurgitation 0.321/0.039
0 48 68.8
1 13 53.9
2 19 52.6
3 7 42.9
4 10 40.0
Culprit vessel  0.001
RCA 63 68.3
LAD 111 46.0
LCX 27 33.3
LM 12 25.0
SVG 7 14.3
Initial TIMI flow 0.846/0.498
0 90 45.6
1 18 50.0
2 41 53.7
3 66 50.0
Culprit lesion type (%) 0.052/0.065
B1 75 52.0
B2 95 52.6
C 39 30.8
Culprit vessel collateral score
(Rentrop)
0.874/0.961
0 128 50.0
1 30 50.0
2 37 46.0
3 8 62.5
Culprit lesion thrombus score 0.018/0.077
0 42 50.0
1 116 41.4
2 13 53.9
3 24 79.2
4 20 50.0
TIMI 2/3 flow or Rentrop 2/3 0.451/NA
“Low flow” 63 44.4
Patent artery 145 51.0
n represents the total number of patients in each angiographic subgroup. One-year
survival was unavailable for one patient. Six patients with severe mitral regurgitation,
left ventricular free wall rupture, or aortic dissection identified post-randomization are
excluded. *Fisher exact test p value/Mantel-Haenszel test for linear trend p value.
†Treatment assignment by characteristic interaction p  0.020 by logistic regression
and p  0.018 by Cox regression.
LAD  left anterior descending artery; LCX  left circumflex artery; LM  left
main coronary artery; NA  not applicable; RCA  right coronary artery;
SHOCK  “SHould we emergently revascularize Occluded Coronaries for cardio-
genic shocK” trial; SVG  saphenous vein graft; TIMI  Thrombolysis In
Myocardial Infarction.
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this is the first report to suggest the importance of early
reperfusion before revascularization in patients with cardio-
genic shock. In the IMS patients who underwent angiog-
raphy, for whom the revascularization rate was low (37%),
extent of coronary artery disease correlated with survival.
However, for the ERV group, which had a high rate of
revascularization (87%), there was no association of extent
of coronary artery disease at baseline and survival in the
shock cohort. The latter observation is not surprising as
revascularization with bypass surgery is known to “neutral-
ize” the impact of the number of diseased coronary arteries
on survival (29,30).
Although inferior myocardial infarction results in fewer
deaths than anterior myocardial infarction for all patients
having myocardial infarction, differential outcome based on
culprit vessel has not been previously reported for patients
with confirmed shock due to predominant left ventricular
failure. In the current study, RCA culprit was associated
with superior survival. The limited subset with complete
data available for the multivariate model and the selective
performance of left ventricular angiography, likely based on
patient stability, preclude a full understanding of the reason
for this observation. Infarction in the distribution of the
RCA can cause shock due to combined right ventricular and
left ventricular dysfunction. Right ventricular dysfunction
may resolve more completely than left ventricular dysfunc-
tion after reperfusion and, therefore, be associated with
improved outcome. The observation that outcome may vary
by culprit vessel should be considered in risk models and in
assuring balanced groups in small randomized trials.
Study limitations. Although 95% of patients assigned to
emergency revascularization had undergone angiography
and had core laboratory review, only two-thirds of patients
assigned to initial medical stabilization were selected to
undergo angiography. Of the remaining third, 45/50 (90%)
died rapidly and were not studied. Therefore, the associa-
tion of anatomic findings and survival in the IMS group is
representative only of survivors of the early phase of shock.
Angiographic findings from the ERV group are most
representative of those that could be expected in patients
with shock similar to those enrolled in this trial because
selection bias is minimized. Furthermore, only 44% of
angiography patients had a left ventriculogram completed
(36% in ERV, 56% in IMS). The difference in percentage of
patients from each group having a left ventriculogram
performed is most likely related to a concern for giving a
contrast load during an acute myocardial infarction compli-
cated by cardiogenic shock. It should also be noted that
Table 4. Multivariate Model for One-Year Survival (n  214): All Angiography Patients
Variables Hazard Ratio for Death 95% CI p Value
Age (yrs) 1.36 per 10 year increase (1.12, 1.65) 0.002
Initial TIMI flow grade 0.85 per 1 grade increase (0.73, 0.99) 0.032
Number of diseased vessels 0.084*
ERV 1.08 per vessel (0.74, 1.57) 0.708
IMS 2.01 per vessel (1.10, 3.69) 0.024
Culprit vessel 0.0004
Right coronary 0.32† (0.18, 0.57)
Left anterior descending 0.78† (0.50, 1.23)
Right coronary vs. left anterior
descending
0.41 (0.32, 0.52)
*p value for treatment group  number of diseased vessels interaction term; †Compared with left circumflex, left main, and
saphenous vein graft.
CI  confidence interval; ERV  emergency revascularization; IMS  initial medical stabilization; TIMI  Thrombolysis
In Myocardial Infarction.
Table 5. Multivariate Model for One-Year Survival (n  73): Left Ventriculogram Cohort
Variables Hazard Ratio for Death 95% CI p Value
Age (yrs) 1.56 per 10 year increase (0.94, 2.28) 0.022
Female 6.35 vs. male (2.33, 17.28)  0.001
Cardiac index 0.51 per 0.5 unit increase (0.30, 0.86) 0.011
LV ejection fraction 0.47 per 10 unit increase (0.28, 0.79) 0.004
Initial TIMI flow grade 0.004*
ERV 0.37 per 1 grade increase (0.21, 0.65)  0.001
IMS 1.36 per 1 grade increase (0.79, 2.36) 0.266
Culprit vessel 0.034
Right coronary 0.27† (0.06, 1.15)
Left anterior descending 0.23† (0.08, 0.73)
Right coronary vs. left
anterior descending
1.15 (0.29, 4.59)
*p value for treatment group  initial TIMI flow grade interaction term; †Compared with left circumflex, left main, and
saphenous vein graft.
CI  confidence interval; ERV  emergency revascularization; IMS  initial medical stabilization; LV  left ventricular;
TIMI  Thrombolysis In Myocardial Infarction.
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LVEF was often measured on inotropic and intraaortic
balloon pump support. Estimates of LVEF and MR pre-
sented here may not be representative of unsupported
cardiogenic shock.
Conclusions. Cardiogenic shock is associated with exten-
sive coronary artery disease and only moderately severe
depression of left ventricular function. Left ventricular
function and the culprit vessel are independently correlated
with one-year survival. Emergency revascularization by
angioplasty or bypass surgery improves survival in cardio-
genic shock by neutralizing the impact of the extent of
coronary artery disease on survival.
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APPENDIX
For a list of committee members, principal investigators,
and study coordinators in the SHOCK trial, please see the
October 15, 2003, issue of JACC at www.cardiosource.com/
jacc.html.
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